Controlling cardiac arrhythmias: To delay conduction or to prolong refractoriness
- 1 September 1989
- journal article
- conference paper
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 3 (5), 671-674
- https://doi.org/10.1007/bf01857618
Abstract
Recent data with encainide and flecainide (CAST study) question the benefit of reducing premature ventricular contractions in survivors of myocardial infarction. Proarrhythmic mechanisms might include excessive slowing of conduction. In patients with supraventricular tachycardias, proarrhythmic effects of Class 1c agents are very uncommon.This publication has 12 references indexed in Scilit:
- EncainideCardiovascular Drugs and Therapy, 1989
- When is QT prolongation antiarrhythmic and when is it proarrhythmic?The American Journal of Cardiology, 1989
- Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunctionThe American Journal of Cardiology, 1988
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.Circulation, 1986
- The cardiac arrhythmia pilot studyThe American Journal of Cardiology, 1986
- Control of cardiac arrhythmias by selective lengthening of repolarization: Theoretic considerations and clinical observationsAmerican Heart Journal, 1985
- Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassificationCardiovascular Research, 1983
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970